NCT03301857 2024-05-20
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Amgen
Phase 4 Completed
Amgen
Shanghai JMT-Bio Inc.
Peking University Third Hospital
Istituto Ortopedico Rizzoli
Sarcoma Alliance for Research through Collaboration